Now is the time: the need to update guidance to expand access to APOE genetic testing
{{output}}
Interest in APOE testing has increased due to an aging population, direct-to-consumer testing options, media coverage and FDA approval of anti-amyloid therapies. Previous Alzheimer's disease (AD) guidelines cautioned against APOE testing in asymptomatic indiv... ...
